Outback Kennels

Parent health testing

• Shar-Pei Autoinflammatory Disease, Thrombopathia, Basset Hound Type, Early Adult Onset Deafness (EAOD), Mucopolysaccharidosis Type IIIB (MPS IIIB), Chondrodystrophy (CDDY and IVDD Risk) with or without Chondrodysplasia (CDPA), Chondrodystrophy, Norwegian Elkhound and Karelian Bear Dog Variant (ITGA10), Chondrodystrophy and IVDD Risk (CDDY-IVDD), Dental Hypomineralization (DH), Craniomandibular Osteopathy (CMO), Skeletal Dysplasia (SD2), Retinal Dysplasia/Oculoskeletal Dysplasia 1 (RD OSD), Hereditary Vitamin D-Resistant Rickets (HVDRR), Cleft Palate (ADAMTS20), Ehlers-Danlos Syndrome, Lethal Acrodermatitis (LAD), Bull Terrier Type, Bald Thigh Syndrome (IGFBP5), Oculocutaneous Albinism, Musladin-Leuke Syndrome (MLS), Hereditary Footpad Hyperkeratosis, Ichthyosis, Great Dane Type, Ichthyosis, Golden Retriever Type 1, Ichthyosis, American Bulldog Type, Ectodermal Dysplasia, Chesapeake Bay Retriever Type, Dystrophic Epidermolysis Bullosa, Adult Paroxysmal Dyskinesia, Episodic Falling Syndrome (EFS), Congenital Myasthenic Syndrome (CMS), Old Danish Pointer Type, Congenital Myasthenic Syndrome (CMS), Labrador Retriever Type, Intestinal Cobalamin Malabsorption (IGS), Komondor Type, Intestinal Cobalamin Malabsorption (IGS CUBN Exon 8), Border Collie Type, Intestinal Cobalamin Malabsorption (IGS CUBN Exon 53), Border Collie Type, Malignant Hyperthermia (MH), Pyruvate Dehydrogenase Phosphatase 1 Deficiency (PDP1), Hypocatalasia, Myotubular Myopathy, Labrador Retriever Type, Nemaline Myopathy, American Bulldog Type, Myotonia Congenita, Schnauzer Type, Myotonia Congenita, Australian Cattle Dog Type, Inherited Myopathy in Great Danes (IMGD), Exercise Induced Collapse (EIC), Centronuclear Myopathy (CNM), Cavalier King Charles Spaniel Muscular Dystrophy (CKCS-MD), Duchenne Muscular Dystrophy, Golden Retriever Type, Long QT Syndrome, Dilated Cardiomyopathy 2 (DCM2), Dilated Cardiomyopathy 1 (DCM1), Sensory Neuropathy, Border Collie Type (SN), Juvenile Laryngeal Paralysis & Polyneuropathy (JLPP), Narcolepsy, Dachshund Type, Narcolepsy, Labrador Retriever Type, Narcolepsy, Doberman Pinscher Type, Polyneuropathy (NDRG1), Alaskan Malamute Type, Neonatal Encephalopathy with Seizures (NEwS), L-2-Hydroxyglutaric Aciduria (L2HGA), Staffordshire Bull Terrier Type, Neuroaxonal Dystrophy (NAD), Rottweiler Type, Neuroaxonal Dystrophy (NAD), Spanish Water Dog Type, X-Linked Tremors, Shaking Puppy Syndrome (SPS), Hypomyelination, Weimaraner Type, Neuroaxonal Dystrophy (NAD), Giant Schnauzer Type, Degenerative Myelopathy (DM; SOD1A), Benign Familial Juvenile Epilepsy (BFJE), Hereditary Ataxia, Cerebellar Ataxia, Spinocerebellar Ataxia (SCA), Neonatal Cortical Cerebellar Degeneration (NCCD), Alexander Disease, Encephalopathy, Alaskan Husky Type, Deafness and Vestibular Dysfunction, Doberman Pinscher Type, Persistent Müllerian Duct Syndrome, Globoid Cell Leukodystrophy (GCL), Terrier Type, GM2 Gangliosidosis, Poodle Type, Gangliosidosis GM2, Japanese Chin Type, GM1 Gangliosidosis, Alaskan Husky Type, Neuronal Degeneration (NDG), Neuronal Ceroid Lipofuscinosis, Saluki Type, Neuronal Ceroid Lipofuscinosis 8 (NCL8), Setter Type, Neuronal Ceroid Lipofuscinosis 7 (NCL7), Neuronal Ceroid Lipofuscinosis 5 (NCL5), Golden Retriever Type, Neuronal Ceroid Lipofuscinosis 12 (NCL12), Australian Cattle Dog Type, Neuronal Ceroid Lipofuscinosis 2 (NCL2), Neuronal Ceroid Lipofuscinosis 8 (NCL8), Australian Shepherd Type, Neuronal Ceroid Lipofuscinosis 5 (NCL5), Border Collie Type, Neuronal Ceroid Lipofuscinosis 1 (NCL1), Dachshund Type, Neuronal Ceroid Lipofuscinosis 10 (NCL10), American Bulldog Type, Lagotto Storage Disease (LSD), Mucopolysaccharidosis VII (MPS VII ARSB), German Shepherd Dog Type, Mucopolysaccharidosis VII (MPS VII), Brazilian Terrier Type, Mucopolysaccharidosis VII (MPS VII GUSB), Shepherd Type, Mucopolysaccharidosis IIIA (MPS IIIA), New Zealand Huntaway Type, Mucopolysaccharidosis IIIA (MPS IIIA), Dachshund Type, Glycogen Storage Disease Type IIIA, GSD IIIA, Glycogen Storage Disease Type II or Pompe's Disease (GSD II), Glycogen Storage Disease Ia, Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND), X-Linked Anhidrotic Ectodermal Dysplasia, Dachshund type, Primary Ciliary Dyskinesia, Kartagner Syndrome (PCD), Fanconi Syndrome, Protein-Losing Nephropathy (PLN; NPHS1 Gene Variant), Primary Hyperoxaluria, Polycystic Kidney Disease (PKD), Hyperuricosuria (HUU), Cystinuria Type II-B, Miniature Pinscher Type, Cystinuria Type II-A, Australian Cattle Dog Type, Cystinuria Type 1A, Newfoundland Type, Macular Corneal Dystrophy, MCD (CHST6), 2,8-Dihydroxyadenine (2,8-DHA) Urolithiasis, Congenital Stationary Night Blindness (CSNB), Primary Lens Luxation (PLL), Primary Open Angle Glaucoma (ADAMST17 Exon 11), Primary Open Angle Glaucoma (ADAMST10 Exon 17), Cone Degeneration, Collie Eye Anomaly (CEA), X-Linked Progressive Retinal Atrophy (XL-PRA), Progressive Retinal Atrophy (PRA), Generalized, Severe Combined Immunodeficiency Disease, Terrier Type, Compliment 3 Deficiency (C3), Bernard-Soulier Syndrome, Cocker Spaniel Type, Ligneous Membranitis, LM (PLG), Trapped Neutrophil Syndrome, Cohen Syndrome (TNS), Pyruvate Kinase Deficiency (PKD), Pug Type, Pyruvate Kinase Deficiency (PKD), Labrador Retriever Type, Pyruvate Kinase Deficiency (PKD), Labrador Retriever Type, Pyruvate Kinase Deficiency (PKD), Terrier Type, Pyruvate Kinase Deficiency, Basenji Type (PKD), Pyruvate Kinase Deficiency (PKD), Beagle Type, Prekallikrein Deficiency, Fletcher Trait, Glanzmann's Thrombasthenia, Otterhound Type, Glanzmann's Thrombasthenia, Great Pyrenees Type, Thrombopathia, American Eskimo Dog Type, von Willebrand Disease I (vWD I), Acral Mutilation Syndrome (AMS), Day Blindness, Achromatopsia, Cone Degeneration, German Shorthaired Pointer Type, DNA Disease Panel

  Show less

  Genetic testing reduces the chance of passing down a wide variety of hereditary diseases of differing prevalence and severity such as Progressive Retinal Atrophy (an eye disease) and Von Willebrand's Disease (a blood disease).

  Show less